Prolight Diagnostics has taken an important step forward with its Psyros point-of-care (POC) diagnostic platform. A recent pre-clinical study showed promising results, confirming that the Psyros system performs well on frozen biobank plasma samples. Following these successful results, attention now turns to the ongoing study at St Thomas’ Hospital in London, where the system is being tested on fresh whole blood. The initial results, which will be available in Q2, are expected to play a crucial role in validating the platform for partners, the market, and shareholders.